Headway was last valued at $2.3B (post-money). It comes from the $125M Series C of Oct 2023. The company is private, so there is no listed share price.
2 valuations. The latest, $2.3B post-money, was set by the Series C in Oct 2023.
A private valuation is the price agreed in one transaction. The Headway valuation of $2.3B is a post-money figure from the Series C dated 1 Oct 2023 — the whole company measured after the $125M raised in that round was already inside it. Subtract the round and the pre-money view of the same deal is $2.2B .
The valuation holds until the next priced round or secondary sale. A private company founded in 2019 with roughly 819 people has no daily price and no order book between rounds.
The routes section explains what is realistically available for a company at this stage.
No. Headway is a private company; its shares do not trade on a public exchange.
The last valuation is $2.3B.
Lead investors for each round are in the funding timeline.
The closest healthcare (mental health / therapist-insurance marketplace) peers are on the competitors page.
Perpetual markets for stocks, gold, indices and pre-IPO names — settled on-chain, no wallet-to-exchange transfers.
